In recent years, chronic respiratory diseases have become the third leading cause of chronic disease death among Chinese residents, second only to cardiovascular and cerebrovascular diseases and tumors. Inhalation administration is the preferred route of administration for the treatment of respiratory diseases. It has the advantages of fast onset of action and few side effects. As a preparation with high R&D barriers and high safety risks, the R&D technology, quality control and packaging system of inhalation preparations are all subject to inhalation. The development of the pharmaceutical industry has brought many challenges.

In order to promote the development of the inhaled preparations industry, improve the R&D level and product quality of inhaled preparations, reduce R&D costs and risks, strengthen exchanges and cooperation between industries, share research results and experiences, and explore the R&D trends and challenges of inhaled preparations.

The Inhalation Preparations Conference will be held at the Suzhou International Expo Center on August 15-16, 2024. The conference is fortunate to invite industry experts, companies, and big names to discuss the research and development, difficulty analysis, competitive advantages, and clinical use of inhalation preparations. Research, industrialization and other related hot topics, jointly answer questions and promote the development and innovation of the inhaled preparation industry!